CRBP

Latest SEC Filings & News for CRBP

2 most recent filings and news items mentioning CRBP. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/CRBP/news?limit=20"

Pull CRBP filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Corbus reports 42.9% ORR for CRB-701 in second-line oropharyngeal cancer

Corbus Pharmaceuticals announced updated Phase 1/2 data showing CRB-701 demonstrated robust activity in second-line oropharyngeal and cervical cancers with confirmed response rates of 42.9% and 34.4% respectively, with a favorable safety profile. The company plans to initiate a r

View filing at SEC.gov →

Corbus Pharmaceuticals appoints Nishant Saxena as Chief Business Officer

Corbus Pharmaceuticals has entered into an employment agreement with Nishant Saxena to serve as Chief Business Officer, effective May 21, 2026, with an annual base salary of $470,000. The appointment reflects the company's leadership expansion in its business development and stra

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.